FOR months, Gary Buesnel was back and forth to see doctors, complaining of stomach aches and pains. Yet repeatedly, medics ...

It was pancreatic cancer - one of the UK ... “He had to go to the UK to have a stent put in because his bile duct was blocked, but because it was the start of Covid, he had to isolate for ...

Liver function improved after endoscopic retrograde cholangiopancreatography and biliary stent placement ... in a long-term complete radiological response. Pancreatic carcinosarcoma is a rare type of ...

Patients with pancreatic cancer have an overall poor prognosis: in most patients, the disease has already spread at the time of diagnosis, resulting in limited treatment options. Nearly 90 percent ...

Pancreatic cancer is one of the deadliest forms of cancer, with an average five-year survival rate of just 13%. More than 80% of patients are diagnosed at an advanced stage when surgery is no ...

The research team found that not only was RAS(ON) multi-selective inhibition effective in preclinical pancreatic cancer models, but it was even more effective when combined with immunotherapy ...

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy. Adding immunotherapy to a new type of ...

CINCINNATI (WKRC) — Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for those living with pancreatic cancer. This trial is ...

A second opinion, which I recommend for everyone, confirmed cholangiocarcinoma, a rare and aggressive bile duct cancer with dismal survival rates and limited treatment options. This was the day that ...

Despite progress in treatments for various cancers, pancreatic cancer continues to pose a significant challenge, with the NHS admitting that it "can be difficult to treat". Early detection is ...